Question to the Department of Health and Social Care:

To ask His Majesty's Government what assessment they have made of the use of AI-integrated health monitoring tools to manage unsupervised use of medications such as semaglutide.

Currently, no assessment has been made on the use of artificial intelligence (AI) to monitor the unsupervised use of these medications. However, we recognise the potential of AI and monitoring systems to support people’s health and care, including through the monitoring of vital signs. The United Kingdom has a world-leading regulatory system which ensures that medical technologies on the market are safe for use, including AI technologies. Should the National Health Service begin to assess AI-integrated health monitoring tools, they will be held to the same regulatory standards as other tools used by the NHS.

Medications such as semaglutide are prescription only medicines and should not be used unsupervised. It is illegal to obtain a prescription medicine without a prescription.